Log inSign Up
Nata Savaścienka CPO
February 2026
The way people interact with their health data is changing fast. Not just what gets measured, but what happens after the measurement. A recent industry report by IntelliProve surveyed five major shifts in digital health, and the common thread across all of them is this: raw data without context is no longer enough. Users expect personalized guidance, and healthcare organizations need systems that can deliver it at scale.
For anyone working in laboratory diagnostics, biomarker testing, or health data infrastructure, these trends are not abstract. They directly affect how blood test results are interpreted, delivered, and acted upon.
Here is what's shifting, what the data says, and why it matters.
The first trend is the move from generic wellness advice to context aware, personalized interventions. Digital health platforms are combining real time biometric signals with medical history, behavioral patterns, and environmental context to predict individual health risks before symptoms appear.
This is not a theoretical concept. According to McKinsey, personalized prevention initiatives could help avoid up to 30% of chronic conditions, significantly cutting long term healthcare costs. And from the user side, Rock Health found that 72% of people express greater trust in digital tools that offer personalized, adaptive guidance. That trust directly translates into more frequent usage, stronger data loops, and better retention.
What this means in practice: when someone uploads their blood test results, they should not just see numbers and reference ranges. They should see what those numbers mean for them specifically, what changed since their last test, and what they can do next. The era of static PDF lab reports is ending. Personalized interpretation is becoming the baseline expectation.
Sweetch, an Israeli digital health company highlighted in the report, illustrates this well. Their platform uses behavioral AI to predict the best moment to engage a user, rather than relying on manual logging or scheduled sessions. The result is lower dropout rates and better adherence to health programs.
Health tracking used to require dedicated devices. Now, advancements in computer vision allow extraction of biomarkers like heart rate and blood pressure through a standard smartphone camera. For health platforms, this dramatically reduces friction in onboarding and continuous monitoring.
But the data on adoption tells an interesting story. A Deloitte survey found that only 34% of consumers trust companies to be transparent about personal data use. And while 78% of U.S. adults say they are willing to share wearable data with providers, only 26.5% actually do (HINTS 6 study). That is a massive gap between intention and action.
The lesson for anyone building health data products: friction and trust are the two biggest barriers. The easier you make it to get value from health data, and the more transparent you are about how that data is handled, the more likely users are to engage. This applies equally to wearable data, contactless measurements, and lab result uploads. If the onboarding flow asks too much before delivering value, people leave.
Mental wellbeing monitoring is shifting from subjective self assessments to objective, real time signals. Platforms are now using heart rate variability, facial micro expressions, sleep patterns, and screen usage data to detect stress and cognitive load far earlier than traditional surveys can.
The urgency is real. The World Health Organization projects that mental health conditions will become the leading cause of disability globally by 2030. Yet early detection at scale remains a challenge. Passive, objective measurement is what makes this scalable.
Wysa, a mental health app featured in the report, demonstrates how this works in practice. It analyzes language patterns, emotional tone, and interaction frequency during everyday AI conversations to detect early signals of anxiety or stress. Over time, it builds a longitudinal emotional profile without requiring users to fill out questionnaires.
For platforms that work with blood test results and biomarker data, there is a relevant connection here. Biomarkers like cortisol, vitamin D, and inflammatory markers (such as CRP) are directly linked to mental health outcomes. The opportunity exists to bridge lab data with behavioral signals to create a more complete picture of a person's wellbeing, not just their physical health.
This trend is about money following conviction. Employers and insurers are shifting from generic wellness perks to targeted, data driven prevention programs. The economic case is strong: employees with access to digital prevention tools are 23% more engaged at work and 32% less likely to be absent (Gallup). A 2025 machine learning study of over 1,100 patients found that participation in preventive care programs reduced hospitalization risk by 38.3% and hospital admissions by 37.7%.
For insurers, this is a dual win: lower long term claim costs and deeper member relationships. For employers, it is about performance and retention, not just wellness.
BetterUp, the coaching platform spotlighted in the report, reported a 90% improvement in work related resilience and a 63% reduction in presenteeism in one customer study. Their model combines AI driven personalization with human coaching, which the report identifies as the emerging standard: hybrid models where AI handles scale and routine, while humans handle complexity.
What this means for lab data providers: enterprise buyers (insurers, employers, health systems) are actively looking for prevention tools they can embed into existing workflows. Blood test interpretation, biomarker tracking over time, and personalized health insights are exactly the type of data layer these programs need. The B2B opportunity here is significant and growing.
The final trend in the report is also the most important. Data collection is now table stakes. The differentiator is what happens after the data is collected. Can the platform turn a blood test result into a specific next step? Can it translate a biomarker trend into a recommendation the user can act on today?
The numbers are clear. McKinsey found that platforms using personalized nudges can boost engagement by up to 35% and significantly reduce churn. Deloitte's 2024 personalization study showed that 80% of consumers expect brands to offer personalized next steps, not just information. If a platform shows data without guidance, users leave.
Noom, featured in the report, exemplifies this approach. Instead of just showing weight trends or calorie counts, it translates every data point into a specific task, nudge, or micro coaching moment adapted to the user's behavior and goals. When stress is detected, it recommends a mindset activity. When activity drops, it prompts a challenge. The key insight: the action has to be immediate, specific, and relevant.
This principle applies directly to how lab results should be delivered. A ferritin level of 15 ng/mL is a data point. "Your iron stores are low, and here is what that means for your energy levels, along with three things you can discuss with your doctor" is an actionable moment. The difference between these two experiences is what separates platforms that retain users from those that don't.
The report includes an interview with Nirmit Upadhyay from Liva Healthcare that is worth noting. His key point: personalization within a product (tailored content, dynamic goals, adaptive nudges) is now table stakes. What most platforms still miss is customization of the offering itself across geographies, cultures, and individual circumstances.
He calls this "Same Product, Different Journey," and it resonates strongly with anyone building health products for multiple markets. A blood test interpretation platform serving users in Nigeria, the UK, and Greece cannot assume one UX fits all. Reference ranges differ, cultural attitudes toward health data vary, and the way people prefer to receive medical guidance is not universal.
Upadhyay also emphasized the "AI first, human focused" model: automation handles routine tasks at scale while human expertise is reserved for the moments that matter most. As he put it, "AI should do the heavy lifting in the background so the human connection can shine in the foreground."
These five trends converge on a single idea: the platforms that win in digital health are not the ones with the most data, but the ones that turn data into something a person can actually do. Whether it is a blood test result, a biomarker trend, a stress signal, or a sleep score, the value is not in the measurement. It is in the moment that follows.
For healthcare organizations, clinical laboratories, and health technology teams, the takeaway is practical. Every insight needs a "so what now?" attached to it. Every data point needs context. And every user interaction is an opportunity to build trust through relevance, not just volume.
The shift from passive reporting to personalized, actionable health guidance is not coming. It is already here.
---
This article draws on findings from IntelliProve's "The 5 Digital Health Tech Trends" report (2025), featuring insights from Sweetch, Wysa, BetterUp, Noom, and Liva Healthcare.
Transform how you deliver lab results to patients while enhancing your practice's efficiency and value. Try BloodGPT or contact us for a personalized demo
Book a Demo
